.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J06B_Immunoglobulins.J06BB15_MumpsImmunoglobulin.MumpsImmunoglobulin .Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J06B_Immunoglobulins.J06BB15_MumpsImmunoglobulin.MumpsImmunoglobulin| name: | MumpsImmunoglobulin | |
| ATC code: | J06BB15 | route: | intramuscular |
| compartments: | 1 | |
| dosage: | 150 | mg |
| volume of distribution: | 0.04 | L |
| clearance: | 0.003 | L/kg/h |
| other parameters in model implementation | ||
Mumps immunoglobulin is a preparation of antibodies derived from human plasma, containing high levels of immunoglobulins (primarily IgG) specific against the mumps virus. It was used as a prophylactic and therapeutic agent for mumps infection, particularly before the availability of mumps vaccines. It is not commonly used today due to the widespread use of effective mumps vaccination.
No specific published pharmacokinetic data exist for mumps immunoglobulin. The following are estimated pharmacokinetic parameters based on general properties of human immunoglobulin G administered intramuscularly to healthy adults.